| Year |
Citation |
Score |
| 2024 |
Ju YH, Cho J, Park JY, Kim H, Hong EB, Park KD, Lee CJ, Chung E, Kim HI, Nam MH. Author Correction: Tonic excitation by astrocytic GABA causes neuropathic pain by augmenting neuronal activity and glucose metabolism. Experimental & Molecular Medicine. PMID 39215091 DOI: 10.1038/s12276-024-01306-y |
0.795 |
|
| 2024 |
Oh JY, Lee H, Jang SY, Kim H, Park G, Serikov A, Jang JH, Kim J, Yang S, Sa M, Lee SE, Han YE, Hwang TY, Jung SJ, Kim HY, ... ... Nam MH, et al. Central Role of Hypothalamic Circuits for Acupuncture's Anti-Parkinsonian Effects. Advanced Science (Weinheim, Baden-Wurttemberg, Germany). e2403245. PMID 39119926 DOI: 10.1002/advs.202403245 |
0.77 |
|
| 2024 |
Nam MH, Na H, Justin Lee C, Yun M. A Key Mediator and Imaging Target in Alzheimer's Disease: Unlocking the Role of Reactive Astrogliosis Through MAOB. Nuclear Medicine and Molecular Imaging. 58: 177-184. PMID 38932762 DOI: 10.1007/s13139-023-00837-y |
0.75 |
|
| 2024 |
Ju YH, Cho J, Park JY, Kim H, Hong EB, Lee CJ, Chung E, Kim HI, Nam MH. Tonic excitation by astrocytic GABA causes neuropathic pain by augmenting neuronal activity and glucose metabolism. Experimental & Molecular Medicine. PMID 38760512 DOI: 10.1038/s12276-024-01232-z |
0.811 |
|
| 2024 |
Cho J, Hong EB, Kim YS, Song J, Ju YH, Kim H, Lee H, Kim H, Nam MH. Baicalin and baicalein from Scutellaria baicalensis Georgi alleviate aberrant neuronal suppression mediated by GABA from reactive astrocytes. Cns Neuroscience & Therapeutics. 30: e14740. PMID 38715318 DOI: 10.1111/cns.14740 |
0.809 |
|
| 2023 |
Kim D, Ko HY, Chung JI, Park YM, Lee S, Kim SY, Kim J, Chun JH, Han KS, Lee M, Ju YH, Park SJ, Park KD, Nam MH, Kim SH, et al. Visualizing Cancer-Originating Acetate Uptake Through MCT1 in Reactive Astrocytes in the Glioblastoma Tumor Microenvironment. Neuro-Oncology. PMID 38085571 DOI: 10.1093/neuonc/noad243 |
0.761 |
|
| 2023 |
Sharma R, Neupane C, Pham TL, Lee M, Lee S, Lee SY, Nam MH, Kim CS, Park JB. Tonic activation of NR2D-containing NMDARs exacerbates dopaminergic neuronal loss in MPTP-injected Parkinsonian mice. The Journal of Neuroscience : the Official Journal of the Society For Neuroscience. PMID 37726169 DOI: 10.1523/JNEUROSCI.1955-22.2023 |
0.304 |
|
| 2023 |
Nam MH, Ko HY, Kim D, Lee S, Park YM, Hyeon SJ, Won W, Chung JI, Kim SY, Jo HH, Oh KT, Han YE, Lee GH, Ju YH, Lee H, et al. Visualizing reactive astrocyte-neuron interaction in Alzheimer's disease using 11C-acetate and 18F-FDG. Brain : a Journal of Neurology. PMID 37062541 DOI: 10.1093/brain/awad037 |
0.73 |
|
| 2023 |
Seo DC, Ju YH, Seo JJ, Oh SJ, Lee CJ, Lee SE, Nam MH. DDC-Promoter-Driven Chemogenetic Activation of SNpc Dopaminergic Neurons Alleviates Parkinsonian Motor Symptoms. International Journal of Molecular Sciences. 24. PMID 36768816 DOI: 10.3390/ijms24032491 |
0.79 |
|
| 2022 |
Kim D, Chun JH, Yi JH, Ko HY, Chung JI, Lee M, Park YM, Nam MH, Kim J, Kim SY, Park Y, Moon JH, Kang SG, Chang JH, Lee CJ, et al. 11C-Acetate PET/CT Detects Reactive Astrogliosis Helping Glioma Classification. Clinical Nuclear Medicine. PMID 35868002 DOI: 10.1097/RLU.0000000000004341 |
0.749 |
|
| 2022 |
Nam MH, Sa M, Ju YH, Park MG, Lee CJ. Revisiting the Role of Astrocytic MAOB in Parkinson's Disease. International Journal of Molecular Sciences. 23. PMID 35457272 DOI: 10.3390/ijms23084453 |
0.806 |
|
| 2022 |
Kim H, Nam MH, Jeong S, Lee H, Oh SJ, Kim J, Choi N, Seong J. Visualization of differential GPCR crosstalk in DRD1-DRD2 heterodimer upon different dopamine levels. Progress in Neurobiology. 102266. PMID 35364139 DOI: 10.1016/j.pneurobio.2022.102266 |
0.582 |
|
| 2022 |
Yoon HH, Ye S, Lim S, Jo A, Lee H, Hong F, Lee SE, Oh SJ, Kim NR, Kim K, Kim BJ, Kim H, Lee CJ, Nam MH, Hur JW, et al. CRISPR-Cas9 Gene Editing Protects from the A53T-SNCA Overexpression-Induced Pathology of Parkinson's Disease . The Crispr Journal. 5: 95-108. PMID 35191750 DOI: 10.1089/crispr.2021.0025 |
0.515 |
|
| 2021 |
Nam MH, Park JH, Song HJ, Choi JW, Kim S, Jang BK, Yoon HH, Heo JY, Lee H, An H, Kim HJ, Park SJ, Cho DW, Yang YS, Han SC, et al. KDS2010, a Newly Developed Reversible MAO-B Inhibitor, as an Effective Therapeutic Candidate for Parkinson's Disease. Neurotherapeutics : the Journal of the American Society For Experimental Neurotherapeutics. PMID 34611843 DOI: 10.1007/s13311-021-01097-4 |
0.736 |
|
| 2021 |
Cho HU, Kim S, Sim J, Yang S, An H, Nam MH, Jang DP, Lee CJ. Redefining differential roles of MAO-A in dopamine degradation and MAO-B in tonic GABA synthesis. Experimental & Molecular Medicine. PMID 34244591 DOI: 10.1038/s12276-021-00646-3 |
0.724 |
|
| 2021 |
An H, Koh W, Kang S, Nam MH, Lee CJ. Differential Proximity of Perisynaptic Astrocytic Best1 at the Excitatory and Inhibitory Tripartite Synapses in APP/PS1 and MAOB-KO Mice Revealed by Lattice Structured Illumination Microscopy. Experimental Neurobiology. PMID 34132201 DOI: 10.5607/en21015 |
0.761 |
|
| 2021 |
An H, Lee H, Yang S, Won W, Lee CJ, Nam MH. Adenovirus-induced Reactive Astrogliosis Exacerbates the Pathology of Parkinson's Disease. Experimental Neurobiology. PMID 34045369 DOI: 10.5607/en21013 |
0.788 |
|
| 2021 |
An H, Heo JY, Lee CJ, Nam MH. The Pathological Role of Astrocytic MAOB in Parkinsonism Revealed by Genetic Ablation and Over-expression of MAOB. Experimental Neurobiology. 30: 113-119. PMID 33972465 DOI: 10.5607/en21007 |
0.644 |
|
| 2020 |
Nam MH, Cho J, Kwon DH, Park JY, Woo J, Lee JM, Lee S, Ko HY, Won W, Kim RG, Song H, Oh SJ, Choi JW, Park KD, Park EK, et al. Excessive Astrocytic GABA Causes Cortical Hypometabolism and Impedes Functional Recovery after Subcortical Stroke. Cell Reports. 32: 107975. PMID 32698009 DOI: 10.1016/j.celrep.2020.107975 |
0.777 |
|
| 2020 |
Nam MH, Won W, Han KS, Lee CJ. Signaling mechanisms of μ-opioid receptor (MOR) in the hippocampus: disinhibition versus astrocytic glutamate regulation. Cellular and Molecular Life Sciences : Cmls. PMID 32671427 DOI: 10.1007/S00018-020-03595-8 |
0.794 |
|
| 2020 |
Nam MH, Cho J, Kwon DH, Park JY, Woo J, Lee J, Lee S, Ko HY, Won W, Kim RG, Song H, Oh SJ, Choi JW, Park KD, Park EK, et al. Excessive Astrocytic GABA Causes Cortical Hypometabolism and Impedes Functional Recovery after Subcortical Stroke. Cell Reports. 32: 107861. PMID 32640227 DOI: 10.1016/J.Celrep.2020.107861 |
0.79 |
|
| 2020 |
Heo JY, Nam MH, Yoon HH, Kim J, Hwang YJ, Won W, Woo DH, Lee JA, Park HJ, Jo S, Lee MJ, Kim S, Shim JE, Jang DP, Kim KI, et al. Aberrant Tonic Inhibition of Dopaminergic Neuronal Activity Causes Motor Symptoms in Animal Models of Parkinson's Disease. Current Biology : Cb. PMID 31928877 DOI: 10.1016/J.Cub.2019.11.079 |
0.798 |
|
| 2019 |
Pandit S, Neupane C, Woo J, Sharma R, Nam MH, Lee GS, Yi MH, Shin N, Kim DW, Cho H, Jeon BH, Kim HW, Lee CJ, Park JB. Bestrophin1-mediated tonic GABA release from reactive astrocytes prevents the development of seizure-prone network in kainate-injected hippocampi. Glia. PMID 31833596 DOI: 10.1002/Glia.23762 |
0.73 |
|
| 2019 |
Nam MH, Han KS, Lee J, Won W, Koh W, Bae JY, Woo J, Kim J, Kwong E, Choi TY, Chun H, Lee SE, Kim SB, Park KD, Choi SY, et al. Activation of Astrocytic μ-Opioid Receptor Causes Conditioned Place Preference. Cell Reports. 28: 1154-1166.e5. PMID 31365861 DOI: 10.1016/J.Celrep.2019.06.071 |
0.764 |
|
| 2019 |
Park JH, Ju YH, Choi JW, Song HJ, Jang BK, Woo J, Chun H, Kim HJ, Shin SJ, Yarishkin O, Jo S, Park M, Yeon SK, Kim S, Kim J, ... Nam MH, et al. Newly developed reversible MAO-B inhibitor circumvents the shortcomings of irreversible inhibitors in Alzheimer's disease. Science Advances. 5: eaav0316. PMID 30906861 DOI: 10.1126/Sciadv.Aav0316 |
0.756 |
|
| 2019 |
Nam M, Han K, Lee J, Won W, Koh W, Bae JY, Woo J, Kim J, Kwong E, Choi T, Chun H, Lee SE, Kim S, Park KD, Choi S, et al. Activation of astrocytic mu-opioid receptor causes conditioned place preference Ibro Reports. 6: S130. DOI: 10.1016/J.Ibror.2019.07.413 |
0.748 |
|
| 2019 |
Ryu H, Shim HS, Choi MH, Ko HY, Yoon M, Kim J, Suk K, Oh S, Nam M, Im H, Hyeon SJ, Nguyen P, Lee J, Lee J, Kowall N, et al. Glia produces endogenous excitotoxin via abnormal metabolism and leads to neuronal damage in Alzheimer's disease Ibro Reports. 6: S16. DOI: 10.1016/J.Ibror.2019.07.036 |
0.382 |
|
| 2018 |
Woo DH, Bae JY, Nam MH, An H, Ju YH, Won J, Choi JH, Hwang EM, Han KS, Bae YC, Lee CJ. Activation of Astrocytic μ-opioid Receptor Elicits Fast Glutamate Release Through TREK-1-Containing K2P Channel in Hippocampal Astrocytes. Frontiers in Cellular Neuroscience. 12: 319. PMID 30319359 DOI: 10.3389/Fncel.2018.00319 |
0.761 |
|
| 2018 |
Nam MH, Han KS, Lee J, Bae JY, An H, Park S, Oh SJ, Kim E, Hwang E, Bae YC, Lee CJ. Expression of µ-Opioid Receptor in CA1 Hippocampal Astrocytes. Experimental Neurobiology. 27: 120-128. PMID 29731678 DOI: 10.5607/En.2018.27.2.120 |
0.81 |
|
| 2017 |
Nam MH, Park M, Park H, Kim Y, Yoon S, Sawant VS, Choi JW, Park JH, Park KD, Min SJ, Lee CJ, Choo H. Indole-substituted benzothiazoles and benzoxazoles as selective and reversible MAO-B inhibitors for treatment of Parkinson's disease. Acs Chemical Neuroscience. PMID 28332824 DOI: 10.1021/Acschemneuro.7B00050 |
0.463 |
|
| Show low-probability matches. |